Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Army
Medtronic
Accenture
Farmers Insurance
Cantor Fitzgerald
Argus Health
Deloitte
Teva
Julphar

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074255

« Back to Dashboard
NDA 074255 describes NADOLOL, which is a drug marketed by Sandoz, Lupin Ltd, Ivax Sub Teva Pharms, Amneal Pharms Co, Invagen Pharms, Zydus Pharms Usa Inc, Teva Pharms, Mylan, Orion Corp Orion, and Impax Labs, and is included in twelve NDAs. It is available from seventeen suppliers. Additional details are available on the NADOLOL profile page.

The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.

Summary for NDA: 074255

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074255

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 074255

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NADOLOL
nadolol
TABLET;ORAL 074255 ANDA Teva Pharmaceuticals USA Inc 0093-4237 0093-4237-01 100 TABLET in 1 BOTTLE (0093-4237-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength80MG
Approval Date:Jan 24, 1996TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength120MG
Approval Date:Jan 24, 1996TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength160MG
Approval Date:Jan 24, 1996TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Boehringer Ingelheim
Covington
Julphar
US Army
Accenture
Colorcon
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot